BioHarvest Sciences Inc. - Common Stock (BHST)
6.5000
+0.0300 (0.46%)
NASDAQ · Last Trade: May 9th, 1:00 PM EDT

BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.
Via Benzinga · March 4, 2025

Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.
Via Benzinga · December 11, 2024